Protocol No.: EAY191-N4
- Title
- A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial
- Principal Investigator
- Pfaendler, Krista
- Phase
- II
- Age Group
- Adult
- Applicable Disease Site
- Gynecologic Cancers
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Carla Ross, RN
- Senior Research Nurse
- Phone: +1 304-293-2633
- Email: carla.ross@hsc.wvu.edu